The Immigration Research Initiative (IRI) located in the Department of Political Science at Concordia University (Montreal) announces its Doctoral Visiting Fellowship competition. IRI is seeking applications for three 3-month doctoral fellowships for the winter of 2023 in the field of immigration.
Funded by the Secrétariat du Québec aux relations canadiennes, IRI’s objective is to build bridges between immigration research in Quebec and elsewhere in the world. Its Doctoral Visiting Fellowship program is designed to support doctoral students who are conducting or who wish to conduct a research project comparing Quebec to the rest of Canada or to other regions of the world.
More specifically, IRI is looking for applicants who wish to develop a project on: 1) immigrant integration and/or attitudes towards immigration, or 2) comparative immigration policies. Both qualitative and quantitative methodologies are welcome. The successful candidate will work in collaboration with Antoine Bilodeau and/or Mireille Paquet.
The award is worth $4000 to cover travel and living expenses while at Concordia University.
The selected candidates must be present at Concordia University for a period of 3 months and must begin their stay before March 1st, 2023. Selected candidates will also be integrated into the activities of the Research Team on Immigration in Contemporary Quebec.
To submit your application
Interested candidates should send the following documents to Antoine Bilodeau and Mireille Paquet:
- A letter describing the candidate’s research expertise
- A one-page description of the proposed research project, highlighting the place of the Quebec case in the project and its relationship to IRI’s objectives, and indicating the stage of development of the project
- A curriculum vitae
- Two letters of reference
For more information or to send your application: antoine.bilodeau@concordia.ca
Applications will be accepted until November 1st, 2022.
Disclaimer: Offers are contingent upon compliance with public health standards related to COVID-19 and receipt of appropriate visas, if required.